Clinical Trials Logo

Clinical Trial Summary

This phase I research protocol is designed to assess immunogenicity and clinical endpoints in patients with human papillomavirus (HPV) 16 cervical intraepithelial neoplasia (CIN)2/3. The protocol tests the use of artesunate in suppository formulation applied intravaginally in patients with cervical dysplasia (CIN2/3). The primary endpoint is to determine and evaluate the safety, tolerability, and feasibility of intravaginal administration of artesunate in health women with CIN2/3.


Clinical Trial Description

Phase I open-label dose escalation study of intravaginal artesunate, formulated in suppositories, in adult females with biopsy-confirmed CIN2/3. Thirty (30) subjects will undergo up to a total of three cycles of intravaginal artesunate. The first cycle will be initiated on Day 0, the second at Week 4, and the third and final cycle at week 8. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02354534
Study type Interventional
Source Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact
Status Completed
Phase Phase 1
Start date February 2015
Completion date November 6, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03196180 - Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia Early Phase 1
Active, not recruiting NCT04484415 - Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) Phase 3
Not yet recruiting NCT06258564 - The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Recruiting NCT04788849 - Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples
Not yet recruiting NCT06273553 - A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 Phase 1/Phase 2
Active, not recruiting NCT02149030 - Effectiveness of Cervical Screening in HPV Vaccinated Women Phase 4
Completed NCT01550783 - Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening N/A
Enrolling by invitation NCT04755517 - Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) N/A
Completed NCT02811367 - The HPV Self-test as a Test of Cure in Madagascar N/A
Completed NCT00081263 - Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Phase 2
Recruiting NCT05405270 - Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Completed NCT04312737 - Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus
Completed NCT02067468 - Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia N/A
Recruiting NCT03366493 - The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection Phase 3
Active, not recruiting NCT03064087 - Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples
Recruiting NCT05851079 - Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
Recruiting NCT03274206 - A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) Phase 2